Omacor - Omega-3 polyunsaturated fatty acids are found in oil from certain types of fish, vegetables, and other plant sources. These fatty acids are not made by the body and must be consumed in the diet. Omega-3 polyunsaturated fatty acids work by lowering the body's production of triglycerides. High levels of triglycerides can lead to coronary artery disease, heart disease, and stroke.
Omega-3 polyunsaturated fatty acids are used together with diet and exercise to help lower triglyceride levels in the blood.
Omega-3 polyunsaturated fatty acids may also be used for purposes not listed in this medication guide.
Omacor capsules contain omega-3-acid ethyl esters(eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). They are more commonly known as omega-3 fatty acids. Omacor also contains alpha-tocopherol (vitamin E).
Omega-3 fatty acids are essential fatty acids, which means they need to be obtained from food because the body cannot produce them. They have various protective effects on the heart and blood circulation.
Omacor (omega-3 fatty acids) decreases the production of 'bad fats', called triglycerides, in the liver. High levels of triglycerides can cause heart disorders and inflammation of the pancreas (pancreatitis).
Omacor also reduces the production of a substance called thromboxane. Reducing its production therefore reduces the risk of heart attacks.
Indications:
to treat high triglyceride levels in the blood (hypertriglyceridaemia)
to reduce the risk of further heart attacks and improving general survival following a heart attack
Isolated or predominant endogenous hypertriglyceridemia in patients at risk of ischemic heart disease and/or pancreatitis, as a supplement to diet when appropriate and assiduous dietary measures alone are insufficient to produce an adequate response.
Post Myocardial Infarction: Adjuvant treatment in secondary prevention after myocardial infarction, in addition to other standard therapy (eg, statins, antiplatelet drugs, β-blockers, ACE inhibitors). Hypertriglyceridemia: Isolated or predominant, endogenous hypertriglyceridemia, as a supplement to diet when dietary measures alone are insufficient to produce an adequate response: Type IV in monotherapy; type IIb/III in combination with statins, when control of triglycerides is insufficient.
Omacor is indicated as an adjunct to diet to reduce very high (≥ 500 mg/dL) triglyceride (TG) levels in adult patients.
Indications: hyperlipidaemias, myocardial infarction
Indications: hyperlipidaemias, myocardial infarction prophylaxis
Indications: hyperlipidaemias, secondary prophylaxis of myocardial infarction
is indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe ( ≥ 500 mg/dL) hypertriglyceridemia.
Used for: Omacor contains highly purified omega-3 polyunsaturated fatty acids.
Omacor belongs to a group of so called reducers of cholesterol and triglycerides.
Omacor is used:
together with other medicines for treatment after a heart attack.
to treat certain forms of increased triglycerides (fats) in the blood after changes to the diet have not worked.
Indications: adjunct to diet and statin in type IIb or III hypertriglyceridaemia; adjunct to diet in type IV hypertri glyceridaemia; adjunct in secondary prevention in those who have had a myocardial infarction in the preceding 3 months